Ultragenyx Pharmaceutical
RARE
RARE
297 hedge funds and large institutions have $3.22B invested in Ultragenyx Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 125 increasing their positions, 104 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
297
Holders Change
-13
Holders Change %
-4.19%
% of All Funds
4.03%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.1%
New
34
Increased
125
Reduced
104
Closed
44
Calls
$43.9M
Puts
$42.2M
Net Calls
+$1.65M
Net Calls Change
+$8.06M
Top Buyers
Top Sellers
| 1 |
VPC
Vestal Point Capital
New York
|
-$36.2M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$26M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$19.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$17.6M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$13.8M |
